Visceral Adiposity Index

OBJECTIVE To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.06–2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (Rs = −0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI. CONCLUSIONS Our study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.

[1]  Xenophon Papademetris,et al.  High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent , 2008, Diabetes.

[2]  J. Després,et al.  Is visceral obesity the cause of the metabolic syndrome? , 2006, Annals of medicine.

[3]  B. Pedersen,et al.  Age-related inflammatory cytokines and disease. , 2003, Immunology and allergy clinics of North America.

[4]  R. Unger.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0870 Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome , 2022 .

[5]  B. Goodpaster,et al.  Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. , 2000, American journal of physiology. Endocrinology and metabolism.

[6]  M. Lombardi,et al.  Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function , 2004, Hypertension.

[7]  J. Després,et al.  Visceral obesity and the heart. , 2008, The international journal of biochemistry & cell biology.

[8]  P. Björntorp.  Body fat distribution, insulin resistance, and metabolic diseases. , 1997, Nutrition.

[9]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.

[10]  D. Rader.  Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. , 2007, The American journal of medicine.

[11]  J. Després,et al.  Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. , 2006, Journal of endocrinological investigation.

[12]  C. Bouchard,et al.  Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. , 1999, Diabetes care.

[13]  P. Björntorp,et al.  The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913 , 1985, Diabetes.

[14]  M. J. Toth,et al.  Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. , 2001, Diabetes care.